Cargando…
Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor.
Autores principales: | Ogata, Takatsugu, Narita, Yukiya, Misawa, Kazunari, Hosoda, Waki, Muro, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813093/ https://www.ncbi.nlm.nih.gov/pubmed/33489132 http://dx.doi.org/10.1002/ccr3.3399 |
Ejemplares similares
-
Dramatic Response in a Patient with Metastatic Gastric Cancer Using Trifluridine/Tipiracil after Rapid Disease Progression while on Nivolumab
por: Nozawa, Kazuki, et al.
Publicado: (2020) -
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center
por: Ando, Masashi, et al.
Publicado: (2023) -
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies
por: Hsieh, Yow-Wen, et al.
Publicado: (2014) -
Survival time after marked reduction in oral intake in terminally ill noncancer patients: A retrospective study
por: Hosoi, Takahiro, et al.
Publicado: (2019) -
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer
por: Bando, Hideaki, et al.
Publicado: (2022)